CLPT
Income statement / Annual
Last year (2025), ClearPoint Neuro Inc's total revenue was $36.97 M,
an increase of 17.78% from the previous year.
In 2025, ClearPoint Neuro Inc's net income was -$25.54 M.
See ClearPoint Neuro Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$36.97 M |
$31.39 M |
$23.96 M |
$20.55 M |
$16.30 M |
$12.83 M |
$11.22 M |
$7.35 M |
$7.38 M |
$5.75 M |
| Cost of Revenue |
$14.28 M
|
$12.27 M
|
$10.34 M
|
$7.02 M
|
$5.18 M
|
$3.71 M
|
$3.94 M
|
$2.43 M
|
$2.90 M
|
$2.64 M
|
| Gross Profit |
$22.69 M
|
$19.12 M
|
$13.61 M
|
$13.53 M
|
$11.12 M
|
$9.12 M
|
$7.28 M
|
$4.92 M
|
$4.48 M
|
$3.11 M
|
| Gross Profit Ratio |
0.61
|
0.61
|
0.57
|
0.66
|
0.68
|
0.71
|
0.65
|
0.67
|
0.61
|
0.54
|
| Research and Development Expenses |
$13.90 M
|
$12.39 M
|
$11.71 M
|
$10.89 M
|
$9.28 M
|
$4.69 M
|
$2.81 M
|
$2.31 M
|
$2.81 M
|
$2.63 M
|
| General & Administrative Expenses |
$16.50 M
|
$12.00 M
|
$11.76 M
|
$9.61 M
|
$8.00 M
|
$5.27 M
|
$4.30 M
|
$4.33 M
|
$4.05 M
|
$4.19 M
|
| Selling & Marketing Expenses |
$16.46 M
|
$14.48 M
|
$12.60 M
|
$9.36 M
|
$7.22 M
|
$5.38 M
|
$4.76 M
|
$3.53 M
|
$3.96 M
|
$3.78 M
|
| Selling, General & Administrative Expenses |
$32.96 M
|
$26.48 M
|
$24.35 M
|
$18.97 M
|
$15.22 M
|
$10.65 M
|
$9.06 M
|
$7.86 M
|
$8.00 M
|
$7.97 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$364.00
|
$16.68 K
|
$0.00
|
| Operating Expenses |
$46.86 M
|
$38.87 M
|
$36.06 M
|
$29.86 M
|
$24.50 M
|
$15.34 M
|
$11.87 M
|
$10.17 M
|
$10.82 M
|
$10.60 M
|
| Cost And Expenses |
$61.14 M
|
$51.14 M
|
$46.40 M
|
$36.88 M
|
$29.67 M
|
$19.05 M
|
$15.81 M
|
$12.60 M
|
$13.72 M
|
$13.24 M
|
| Interest Income |
$1.21 M
|
$872.00 K
|
$386.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$8.81 K
|
| Interest Expense |
$2.39 M
|
$0.00
|
$0.00
|
$81.00 K
|
$973.00 K
|
$1.44 M
|
$955.00 K
|
$980.38 K
|
$872.93 K
|
$1.06 M
|
| Depreciation & Amortization |
$2.24 M
|
$1.90 M
|
$1.46 M
|
$777.00 K
|
$692.00 K
|
$550.00 K
|
$251.00 K
|
$109.44 K
|
$116.45 K
|
$155.71 K
|
| EBITDA |
-$21.93 M |
-$17.84 M |
-$20.99 M |
-$15.58 M |
-$12.75 M |
-$4.79 M |
-$4.33 M |
-$5.07 M |
-$6.18 M |
-$6.85 M |
| EBITDA Ratio |
-0.59
|
-0.57
|
-0.88
|
-0.76
|
-0.78
|
-0.37
|
-0.39
|
-0.69
|
-0.84
|
-1.19
|
| Operating Income Ratio |
-0.65
|
-0.63
|
-0.94
|
-0.79
|
-0.82
|
-0.48
|
-0.41
|
-0.71
|
-0.86
|
-1.3
|
| Total Other Income/Expenses Net |
-$1.32 M
|
$832.00 K
|
$357.00 K
|
-$103.00 K
|
-$1.04 M
|
-$562.00 K
|
-$946.00 K
|
-$915.70 K
|
-$831.52 K
|
-$581.16 K
|
| Income Before Tax |
-$25.49 M
|
-$18.91 M
|
-$22.09 M
|
-$16.44 M
|
-$14.41 M
|
-$6.78 M
|
-$5.54 M
|
-$6.16 M
|
-$7.17 M
|
-$8.07 M
|
| Income Before Tax Ratio |
-0.69
|
-0.6
|
-0.92
|
-0.8
|
-0.88
|
-0.53
|
-0.49
|
-0.84
|
-0.97
|
-1.4
|
| Income Tax Expense |
$55.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$25.54 M
|
-$18.91 M
|
-$22.09 M
|
-$16.44 M
|
-$14.41 M
|
-$6.78 M
|
-$5.54 M
|
-$6.16 M
|
-$7.17 M
|
-$8.07 M
|
| Net Income Ratio |
-0.69
|
-0.6
|
-0.92
|
-0.8
|
-0.88
|
-0.53
|
-0.49
|
-0.84
|
-0.97
|
-1.4
|
| EPS |
-0.9 |
-0.7 |
-0.9 |
-0.68 |
-0.69 |
-0.43 |
-0.49 |
-0.56 |
-0.93 |
-2.93 |
| EPS Diluted |
-0.9 |
-0.7 |
-0.9 |
-0.68 |
-0.69 |
-0.43 |
-0.49 |
-0.56 |
-0.93 |
-2.93 |
| Weighted Average Shares Out |
$28.32 M
|
$27.03 M
|
$24.61 M
|
$24.18 M
|
$20.73 M
|
$15.85 M
|
$13.16 M
|
$10.93 M
|
$7.74 M
|
$2.75 M
|
| Weighted Average Shares Out Diluted |
$28.32 M
|
$27.03 M
|
$24.61 M
|
$24.18 M
|
$20.73 M
|
$15.85 M
|
$13.16 M
|
$10.93 M
|
$7.74 M
|
$2.75 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
